Episodic Migraine: Phase 3 Study of BOTOX (Botulinum Toxin Type A) for the Prevention of Migraine in Subjects with Episodic Migraine

12523M21-307/NCT05028569Open (affiliates only)Episodic Migraine: Phase 3 Study of BOTOX (Botulinum Toxin Type A) for the Prevention of Migraine in Subjects with Episodic MigraineM21-307NCT05028569IndustrialAdultTreatmentIIIOtherDougherty, CarrieGeorgetown University Medical Center : Charles CarpenterGUMC Neurology14264Charles CarpenterCharles Carpentercjc357@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>